Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Pradaxa 150mg capsules
0208020X0BBACAC
|
Pradaxa | Dabigatran etexilate | Cardiovascular System | 937 |
|
Pradaxa 110mg capsules
0208020X0BBABAB
|
Pradaxa | Dabigatran etexilate | Cardiovascular System | 835 |
|
Pradaxa 75mg capsules
0208020X0BBAAAA
|
Pradaxa | Dabigatran etexilate | Cardiovascular System | 18 |
|
Pradaxa 20mg granules sachets
0208020X0BBADAD
|
Pradaxa | Dabigatran etexilate | Cardiovascular System | 1 |
|
Pradaxa 110mg granules sachets
0208020X0BBAHAH
|
Pradaxa | Dabigatran etexilate | Cardiovascular System | No data available |
|
Pradaxa 150mg granules sachets
0208020X0BBAIAI
|
Pradaxa | Dabigatran etexilate | Cardiovascular System | No data available |
|
Pradaxa 30mg granules sachets
0208020X0BBAEAE
|
Pradaxa | Dabigatran etexilate | Cardiovascular System | No data available |
|
Pradaxa 40mg granules sachets
0208020X0BBAFAF
|
Pradaxa | Dabigatran etexilate | Cardiovascular System | No data available |
|
Pradaxa 50mg granules sachets
0208020X0BBAGAG
|
Pradaxa | Dabigatran etexilate | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.